Agenus (Formerly known as Antigenics Inc. - New York)

108 articles about Agenus (Formerly known as Antigenics Inc. - New York)

• Antigenics Inc. (New York) to Report Third Quarter 2008 Financial Results on November 5, 2008; Conference Call to Follow

  10/31/2008

• Antigenics Inc. (New York) Submits Oncophage(R) Application for European Approval

  10/22/2008

• FDA Grants Permission For Export of Antigenics Inc. (New York)' Oncophage(R) to Russia

  9/29/2008

• Antigenics Inc. (New York) to Present at the UBS Warburg 2008 Global Life Sciences Conference

  9/15/2008

• Antigenics Inc. (New York) Reports Second Quarter 2008 Financial Results

  7/31/2008

• Antigenics Inc. (New York) to Report Second Quarter 2008 Financial Results on July 31, 2008; Conference Call to Follow

  7/24/2008

• Antigenics Inc. (New York) to Webcast 2008 Annual Shareholders Meeting

  5/21/2008

• Antigenics Inc. (New York) to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference

  5/13/2008

• Antigenics Inc. (New York) Reports First Quarter 2008 Financial Results

  5/1/2008

• Antigenics Inc. (New York) to Report First Quarter 2008 Financial Results on May 1, 2008; Conference Call to Follow

  4/24/2008

• Antigenics Inc. (New York) Raises $21M in Private Placement

  4/9/2008

• Antigenics Inc. (New York)'s Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer

  4/8/2008

• Antigenics Inc. (New York) to Present Phase 3 Oncophage(R) (vitespen) Data in Kidney Cancer at European Association of Urology Annual Congress

  3/21/2008

• Antigenics Inc. (New York) Reports Fourth Quarter and Year-End 2007 Financial Results

  2/21/2008

• Antigenics Inc. (New York) Cancer Vaccine Study Shows Mixed Results

  2/20/2008

• Antigenics Inc. (New York) to Report Fourth Quarter and Year-End 2007 Financial Results on February 21, 2008; Conference Call to Follow

  2/14/2008

• Antigenics Inc. (New York) Reports Positive Data on QS-21 Stimulon(R) Adjuvant in Acambis' Influenza A Vaccine

  1/3/2008

• Antigenics Inc. (New York): Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  10/26/2007

• Antigenics Inc. (New York) Says Cancer Vaccine Study Shows Promise

  10/26/2007

• Antigenics Inc. (New York) to Report Third Quarter 2007 Financial Results on November 1, 2007; Conference Call to Follow

  10/25/2007